Bupropion Hydrochloride
- Product NDC
- 71335-0687
- 11-digit product format
- 713350687
- Labeler code
- 71335
- Product ID
- 71335-0687_ee22c939-14df-4a5d-a7a2-ef5153781357
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA090693
- Marketing category
- ANDA
- Marketing start
- 2017-06-14
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0687-1 | 71335068701 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0687-1) | 2018-02-15 | 0000-00-00 | No | No | Current |
| 71335-0687-2 | 71335068702 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0687-2) | 2018-02-15 | 0000-00-00 | No | No | Current |
| 71335-0687-3 | 71335068703 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0687-3) | 2018-02-15 | 0000-00-00 | No | No | Current |
| 71335-0687-4 | 71335068704 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0687-4) | 2018-02-15 | 0000-00-00 | No | No | Current |
| 71335-0687-5 | 71335068705 | 8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0687-5) | 2018-02-15 | 0000-00-00 | No | No | Current |